BioAlps’ "4à6" are a series of events organized in each of the 7 cantons of Western Switzerland.

Taking place from 4PM to 6PM, this series of events enables you to visit the major regional actors in the biotech and medtech fields.

Organized by: BioAlps and the Promotion économique du canton de Neuchâtel
Location: Route des Falaises 74, 2000 Neuchâtel
Date: Wednesday 16 May 2018 from 4PM to 6PM

Description : Founded in 2009, Swiss Advanced Vision (SAV-IOL) designs, manufactures and distributes high quality intraocular lenses (IOLs) used in cataract surgery. Based on patented EDOF (extended depth-of-focus) technology, SAV-IOL is set to revolutionize the ophthalmic market by introducing a pipeline of next generation IOL solutions.

In 2016, SAV-IOL launched InFo, a premium EDOF lens for the multifocal market to correct post cataract vision, using a combination of optical elements to provide continuous near to distant vision, while minimizing potential visual disturbances. In 2017, SAV-IOL launched Lucidis, an EDOF lens with refractive design to address the monofocal market.

During this 4à6 event, you will have the opportunity to visit the manufacturing facility of SAV-IOL to see how intraocular lenses are made along with a brief presentation of the most advanced projects SAV-IOL is working on.

 

Please use the below registration form to sign up for the event :

Title
First Name
Name
Company
Function
Address
Zip, locality
Phone
E-mail

  
Please enter the security code above in the space provided.


 

 



Find an actor

4à6 de BioAlps - UCB Farchim20.06.2018

Les "4à6" de BioAlps sont une série d'événements organisés dans chacun des 7 cantons de Suisse occidentale.

Interview du nouveau Président de BioAlps par l'Agefi

Philippe D. Monnier a parlé avec Claude Clément, nouveau Président de BioAlps, de son nouveau rôle et sa vision...
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn